Nonoxidative modifications of lipoproteins in atherogenesis.
about
Intracellular cholesterol transportFurther evaluation of plasma sphingomyelin levels as a risk factor for coronary artery diseaseApolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosisMolecular etiology of atherogenesis--in vitro induction of lipidosis in macrophages with a new LDL modelMacrophages create an acidic extracellular hydrolytic compartment to digest aggregated lipoproteins.Plasmin promotes foam cell formation by increasing macrophage catabolism of aggregated low-density lipoprotein.Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration.Studies of metabolite-protein interactions: a reviewEffect of oxidized low-density lipoprotein concentration polarization on human smooth muscle cells' proliferation, cycle, apoptosis and oxidized low-density lipoprotein uptake.Aggregation and fusion of low-density lipoproteins in vivo and in vitro.C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipidsAging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins.Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficienApolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy.Monocyte-Derived Dendritic Cells Upregulate Extracellular Catabolism of Aggregated Low-Density Lipoprotein on Maturation, Leading to Foam Cell FormationScreening for suspected coronary heart disease in patients, using integrated serum biochemical indices.Mast cells: multipotent local effector cells in atherothrombosis.Size-selective uptake of colloidal low density lipoprotein aggregates by cultured white blood cellsEarly atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans.Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice.Generation in human plasma of misfolded, aggregation-prone electronegative low density lipoprotein.Macrophages of genetically characterized familial hypercholesterolaemia patients show up-regulation of LDL-receptor-related proteinsMolecular biology of atherosclerosis.Lysosomes, cholesterol and atherosclerosis.Aggregated LDL in contact with macrophages induces local increases in free cholesterol levels that regulate local actin polymerization.The uptake and degradation of matrix-bound lipoproteins by macrophages require an intact actin Cytoskeleton, Rho family GTPases, and myosin ATPase activity.The cytoplasmic domain of the low density lipoprotein (LDL) receptor-related protein, but not that of the LDL receptor, triggers phagocytosis.Apoptosis and plaque destabilization in atherosclerosis: the role of macrophage apoptosis induced by cholesterol.Suppression of EC-SOD by oxLDL During Vascular Smooth Muscle Cell Proliferation.Atherosclerosis
P2860
Q24553317-8E52A6CC-D536-4C0B-A6DB-C900F333FDB7Q25255535-CDFEC774-127E-4AB1-8C76-66274DCFF23EQ28278173-55EA14BC-5934-418C-8A95-0AEAF730ADA7Q28482296-15FB2924-3F57-4E0E-855C-F9AC5007119AQ30492073-4592F932-8499-42F8-B7D0-97B9BC74B24EQ30541611-E09B84A9-2B6A-4A14-8818-2577B5E06E34Q33634096-7282EDC4-A330-4B83-9348-0D1EDDBECC57Q33657421-FBBA132D-37F8-4978-9E26-7F6FA7C9971CQ34065792-62A51A92-0600-4B41-A672-7EF1A1600AB2Q34133240-9039E830-3948-4776-8B14-D104E22E4BFDQ34191416-763209AF-AC92-46F3-A386-9EFB835A71A5Q35056603-F8FBEE61-225D-4F4D-AEA3-DFDCB39AEA40Q35088381-CF4D3EAB-9F41-4A35-ACAD-228C986E4A6FQ35749021-8AE07187-CA23-45FD-BEC3-A3FE8FB8D5A2Q36093861-0C64AB30-5E0E-424B-9E75-4344395F2928Q36577207-C817D427-BEB5-45AF-9554-1DA90EDF3303Q36819891-F80B0A21-C4FE-40B6-9DB3-296F66196785Q37036917-E82CCBD2-A84E-4583-9B0A-1349A1A2E78CQ37145550-C469B4CC-1CB8-44C5-93D9-D4D178B02AEAQ37151524-25010366-4CBD-4CD7-BE8A-6CD1A33B9423Q37263281-FA7297AD-CBBD-4634-86CD-A1DCD2D75595Q37662861-B32A99FF-580E-4BF9-8BB8-350A4AA8B665Q38125279-199F8075-E44C-4AEA-BAA7-146625D6C1E3Q42122586-4AAD3619-9A0A-43D3-BDAD-1E657C8C9E72Q42574419-1788E066-0FC9-4D1F-99D2-615623E6B25AQ43690437-896C54EF-D747-4A1F-8A44-8899B64AF771Q44564192-80273DD1-B939-47B3-B474-13F254CA67A5Q44895988-649730C0-66BD-4627-B7C9-03AD838C96FEQ46577733-9A620D66-3735-4451-AC3C-C0ACDEF987F6Q57132044-587D4E82-9344-4DA2-AD7B-473DCE00F443
P2860
Nonoxidative modifications of lipoproteins in atherogenesis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Nonoxidative modifications of lipoproteins in atherogenesis.
@ast
Nonoxidative modifications of lipoproteins in atherogenesis.
@en
type
label
Nonoxidative modifications of lipoproteins in atherogenesis.
@ast
Nonoxidative modifications of lipoproteins in atherogenesis.
@en
prefLabel
Nonoxidative modifications of lipoproteins in atherogenesis.
@ast
Nonoxidative modifications of lipoproteins in atherogenesis.
@en
P1476
Nonoxidative modifications of lipoproteins in atherogenesis.
@en
P2093
P304
P356
10.1146/ANNUREV.NUTR.19.1.123
P407
P577
1999-01-01T00:00:00Z